Opening book details…
About this Medicine article
Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study by Van Cutsem, E; Yoshino, T; Lenz, H J; Lonardi, S; Falcone, A; Limón, M L; Saunders, M; Sobrero, A; Park, Y S; Ferreiro, R; Hong, Y S; Tomasek, J; Taniguchi, H; Ciardiello, F; Stoehr, J; Oum’Hamed, Z; Vlassak, S; Studeny, M; Argiles, G is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Van Cutsem, E; Yoshino, T; Lenz, H J; Lonardi, S; Falcone, A; Limón, M L; Saunders, M; Sobrero, A; Park, Y S; Ferreiro, R; Hong, Y S; Tomasek, J; Taniguchi, H; Ciardiello, F; Stoehr, J; Oum’Hamed, Z; Vlassak, S; Studeny, M; Argiles, G
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2018
- Language
- EN
- Field
- Medicine (Health Sciences)